The TOF3D Mechanomyograph. Evaluation of a New Device for Assessment of the Neuromuscular Block.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorKlinikum Hersfeld-Rotenburg

About this trial

In clinical anesthesiologic practice, most institutions use acceleromyography in order to assess the degree of a neuromuscular block.

The aim of the present study is to assess a new device using mechanomyography. Until recently, this method was reserved for experimental settings. It seems to be able to work more precisely, and additionally, it offers the opportunity to use other stimulation patterns than acceleromyographic measurements.

The investigation is divided into two parts:

Part 1 compares the mechanomyograph directly with an acceleromyograph. In part 2, two mechanomyographs using different stimulation patterns are compared with each other.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients scheduled for surgery requiring general anesthesia with neuromuscular blocking agents

Disqualifiers

anticipated or known difficult airway

increased risk for aspiration

pregnancy

neuromuscular disorders

Trial design

Design model

Parallel

Treatments tested in this trial

  • measurement of the time course of a neuromuscular block

    Device

    a new device is compared to an established one.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: comparison of mechanomyograph and acceleromyographOther 1 intervention
Group B: comparison of tetanic fade versus train of four ratioOther 1 intervention

Trial outcomes

Primary outcomes

1

difference in time to recovery to a train of four ratio of 1,0.

difference in time to recovery to a train of four ratio of 1,0 measured by acceleromyography and mechanomyography, respectively

Time frame
from enrollment to the end of anesthesiologic treatment at the day of surgery (2-3 weeks after enrollment)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.